| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 5e-05 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |